Best- and Worst-Performing Stocks
Micron and Intel rank among the best stocks in Q2 2026, while the worst include Accenture and Intuit.

The Morningstar US Large-Mid Cap Index rose 15.63% in the second quarter amid a rally in the technology sector. The index tracks the top 90% of the US investable universe by market cap, and each quarter, we screen it for the best- and worst-performing companies. Data in this article is sourced from Morningstar Direct.
The Best-Performing Stocks of Q2 2026
The Worst-Performing Stocks of Q2 2026
Metrics for the Best-Performing Stocks
Astera Labs
- Sector: Technology
- Industry: Semiconductors
- Economic Moat: Not Rated
Astera soared 340.71% in the quarter, leaving the stock up 434.20% for the past year. The stock has a quantitative Morningstar Rating of 1 star.
Sandisk
- Sector: Technology
- Industry: Computer Hardware
- Economic Moat: None
Sandisk surged 257.88% in the quarter, leaving it up 4913.74% for the past year. The stock has a Morningstar Rating of 1 star, trading at a 127% premium to its fair value estimate of $1,000 per share.
Micron Technology
- Sector: Technology
- Industry: Semiconductors
- Economic Moat: None
Micron soared 241.67% in the quarter, leaving the stock up 838.82% for the past year. The stock has a Morningstar Rating of 2 stars and trades at a 36% premium to its fair value estimate of $850 per share.
Intel
- Sector: Technology
- Industry: Semiconductors
- Economic Moat: None
Intel climbed 216.41% in the quarter, leaving shares up 523.35% for the past year. Intel has a Morningstar Rating of 2 stars, trading at a 55% premium to its fair value estimate of $90 per share.
Marvell Technology
- Sector: Technology
- Industry: Semiconductors
- Economic Moat: Narrow
Marvell surged 200.89% in the quarter, leaving it up 285.92% for the past year. The stock has a Morningstar Rating of 2 stars, trading at a 27% premium to its fair value estimate of $235 per share.
Metrics for the Worst-Performing Stocks
Intuit
- Sector: Technology
- Industry: Software - Application
- Economic Moat: Narrow
Intuit dove 39.44% in the quarter, leaving shares down 66.58% for the past year. Stocks in the company were 67.92% below their last high on July 30, 2025. Intuit has a Morningstar Rating of 5 stars, trading at a 43% discount to its fair value estimate of $455 per share.
Zoetis
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Economic Moat: Wide
Zoetis sank 38.95% in the quarter, leaving the stock down 53.20% for the past year. Shares were 55.58% lower than their last high on July 10, 2025. The stock has a Morningstar Rating of 5 stars and trades at a 49% discount to its fair value estimate of $140 per share.
Accenture
- Sector: Technology
- Industry: Information Technology Services
- Economic Moat: Narrow
Accenture plunged 36.69% in the quarter, leaving it down 57.25% for the past year. Shares were 59.57% below their last high on July 8, 2025. The stock has a Morningstar Rating of 5 stars, trading at a 44% discount to its fair value estimate of $223 per share.
Cognizant Technology Solutions
- Sector: Technology
- Industry: Information Technology Services
- Economic Moat: Narrow
Cognizant sank 36.47% in the quarter, leaving the stock down 49.36% for the past year. Shares were 55.51% lower than their last high on Jan. 14, 2026. The stock has a Morningstar Rating of 5 stars and trades at a 54% discount to its fair value estimate of $84 per share.
Insmed
- Sector: Healthcare
- Industry: Biotechnology
- Economic Moat: Not Rated
Insmed plunged 34.80% in the quarter, while shares were still up 5.94% for the past year. Shares were 49.88% below their last high on Dec. 2, 2025. The stock has a quantitative Morningstar Rating of 3 stars.
Companies not formally covered by a Morningstar analyst are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative star rating.
This article was generated with the help of automation and reviewed by Morningstar editors. Learn more about Morningstar’s use of automation.
The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.
